Details for: ENBREL
Company: IMMUNEX CORPORATION
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02242903 | ENBREL | ETANERCEPT; WATER | 25 MG / KIT; 1 ML / KIT | POWDER FOR SOLUTION | SUBCUTANEOUS |
| 02242903 | ENBREL | ETANERCEPT; WATER | 25 MG / KIT; 1 ML / KIT | LIQUID | SUBCUTANEOUS |
| 02242903 | ENBREL | ETANERCEPT; WATER | 25 MG / KIT; 1 ML / KIT | KIT | SUBCUTANEOUS |
| 02274728 | ENBREL | ETANERCEPT | 50 MG / ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Regulatory Decision Summary
Summary Safety Review - ENBREL (etanercept) - Assessing the potential harm to the developing babies of mothers treated with ENBREL
Summary Safety Review - ENBREL (etanercept) - Schizophrenia like symptoms
Summary Safety Review - Tumour necrosis factor (TNF) blockers - Glioblastoma (brain tumour)
Summary Safety Review - ENBREL (etanercept) - Assessing the potential harm to the developing babies of mothers treated with ENBREL
Summary Safety Review - ENBREL (etanercept) - Schizophrenia like symptoms
Summary Safety Review - Tumour necrosis factor (TNF) blockers - Glioblastoma (brain tumour)
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.